Company / Capital Expenditures
Collegium Pharmaceutical, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.7M
FY2025
5-year range
$461.0K / $1.9M
FY2021-FY2025
Trend
+5.3%
vs FY2024
Sector context
#98 of 195
Health Care
What the data says
At $2M, Collegium Pharmaceutical, Inc.'s capital expenditures ranks #98 of 195 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $362,000 in FY2017 to $6M in FY2019.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -20.7%.
Improved from $461,000 to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +2.4%
- 5-Year CAGR
- -20.7%
- 10-Year CAGR
- -
Sector benchmark
#98 of 195 in Health CareTop 50% of 195This company $1.7M Sector average $116.9M
▼
-98.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -20.7%, indicating a declining trend.
- In FY2025, capital expenditures increased 5.3% year-over-year.
- Ranks #98 out of 195 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7M | +5.3% |
| FY2024 | $1.7M | +258.4% |
| FY2023 | $461.0K | -71.6% |
| FY2022 | $1.6M | -16.6% |
| FY2021 | $1.9M | -64.9% |
| FY2020 | $5.5M | -13.9% |
| FY2019 | $6.4M | +17.5% |
| FY2018 | $5.5M | +1413.0% |
| FY2017 | $362.0K | -24.1% |
| FY2016 | $477.0K | +31.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026